Category Healthcare News

World’s First MEVION S250 Proton Therapy Treatment Delivered at Barnes-Jewish Hospital

Dec31

By a News Reporter-Staff News Editor at Cancer Weekly Proton therapy delivers highly precise doses of radiation while limiting unnecessary radiation to healthy tissue, potentially decreasing radiation side effects and improving patient outcomes. Mevion’s ability to provide this advanced treatment in a compact form is an industry first, leading the way in providing patients and […]

Chongqing Lummy Temodar Bulk Drug Nodded for Sale in US

Dec31

CHONGQING, December 31, SinoCast Chongqing Lummy Pharmaceutical Co., Ltd. (SZSE: 300006) revealed a notice received from the Food and Drug Administration (FDA), approving the Chinese drug maker to sell off Temodar bulk drug in US, which will widen potential market destination, optimize product portfolios and further promote its products abroad.

Sunshine State Health Plan Rebrands As Sunshine Health

Dec31

SUNRISE, Fla., Dec. 31, 2013 /PRNewswire/ Sunshine State Health Plan, a subsidiary of Centene Corporation, is undergoing a statewide rebranding initiative to increase exposure of the multiple managed care services it offers in Florida. As of January 1, 2014, Sunshine State Health Plan will officially launch its new brand, including a new logo and marketing […]

Audio-Digest Foundation Announces the Release of Emergency Medicine Volume 30, Issue 17: Pulmonary Disease

Dec31

Glendale, CA (PRWEB) December 31, 2013 Audio-Digest Foundation announces the release of Emergency Medicine Volume 30, Issue 17: Pulmonary Disease. The goal of this program is to improve the management of asthma, chronic obstructive pulmonary disease (COPD), and pneumonia in the emergency department. After hearing and assimilating this program, the clinician will be better able […]

AMN Healthcare CEO Susan Salka Recognized as Top Influential

Dec31

SAN DIEGO, Dec. 31, 2013 /PRNewswire/ AMN Healthcare Services, Inc. (NYSE: AHS), the innovator in healthcare workforce solutions and largest provider of staffing services in the nation, announced today that Susan Salka, AMN’s President, CEO and Director, has been named one of San Diego’s “Top Influentials” in The Daily Transcript | San Diego Source. This […]

IGI Laboratories Completes Sixth ANDA Filing for 2013 Under Joint Drug Development And Commercialization Agreement

Dec31

IGI Laboratories (NYSE MKT: IG) today announced it executed a license, development, supply and marketing agreement with a large multi-national pharmaceutical company.  In accordance with the confidentiality agreement in place, the name of the company remains undisclosed.  The agreement designates IGI Laboratories, Inc. (IGI) as the developer and manufacturer of a generic topical pharmaceutical drug […]

United States : Veloxis Pharmaceuticals SUBMITS NDA to the US FDA [TendersInfo (India)]

Dec31

Veloxis Pharmaceuticals A/S has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the marketing and sale of Envarsus (formerly LCP-Tacro ) for the prevention of organ rejection in kidney transplant recipients. The submission is based on the whole data set from the company’s clinical development program […]

Huntsman Cancer Institute Discovery Translates into Clinical FDA-Cleared Breast Cancer Test at ARUP Laboratories

Dec31

By a News Reporter-Staff News Editor at Cancer Weekly The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk […]

Findings from Borgess Medical Center in the Area of Algorithms Reported

Dec31

By a News Reporter-Staff News Editor at Journal of Mathematics Fresh data on Algorithms are presented in a new report. According to news reporting originating in Kalamazoo, Michigan, by VerticalNews journalists, research stated, “Despite increased recanalization rates in the treatment of acute ischemic stroke, the percentage of patients with a good clinical outcome of all […]

Cubist Announces FDA Acceptance of Tedizolid New Drug Application; Genzyme Receives CRL from FDA on Lemtrada Application

Dec31

Below is a look at some of the headlines for companies that made news in the healthcare sector on December 30, 2013.{nfg}Cubist Pharmaceuticals (NASDAQ: CBST) announced the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for its investigational antibiotic tedizolid phosphate (TR-701) with Priority Review. The FDA has assigned […]